Literature DB >> 18077787

Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.

Gillian A Lang1, T Scott Devera, Mark L Lang.   

Abstract

Activation of natural killer-like T (NKT) cells with the CD1d ligand alpha-galactosylceramide enhances T-dependent humoral immune responses against coadministered T-dependent Ag. At present, there is little information on the mechanisms involved other than a dependence on CD1d expression by antigen-presenting cells and/or development of the NKT subset. We therefore tested the hypothesis that direct presentation of alpha-GC by B cells was required for NKT-enhanced Ab responses against T-dependent Ag. We reconstituted B cell-deficient microMT mice with B cells from C57Bl/6 donors or CD1d(-/-) donors before immunization with NP-KLH alone or NP-KLH mixed with alpha-GC. We made the surprising observation that B-cell expression of CD1d is absolutely required for the NKT-enhanced Ab response. Our data show that the mechanism by which NKT cells enhance humoral immune responses involves interaction with CD1d-expressing B cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077787      PMCID: PMC2234052          DOI: 10.1182/blood-2007-10-117309

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.

Authors:  H Kitamura; A Ohta; M Sekimoto; M Sato; K Iwakabe; M Nakui; T Yahata; H Meng; T Koda; S Nishimura; T Kawano; M Taniguchi; T Nishimura
Journal:  Cell Immunol       Date:  2000-01-10       Impact factor: 4.868

4.  Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi.

Authors:  H Kumar; A Belperron; S W Barthold; L K Bockenstedt
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Innate immune response to encephalomyocarditis virus infection mediated by CD1d.

Authors:  Mark A Exley; Nancy J Bigley; Olivia Cheng; Angela Shaulov; Syed Muhammad Ali Tahir; Quincy L Carter; Jorge Garcia; Carren Wang; Kurt Patten; Harold F Stills; Frederick W Alt; Scott B Snapper; Steven P Balk
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

6.  Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

Authors:  Shin-ichiro Fujii; Kanako Shimizu; Mitchell Kronenberg; Ralph M Steinman
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

7.  Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.

Authors:  Mariette Lisbonne; Séverine Diem; Alexandre de Castro Keller; Jean Lefort; Luiza M Araujo; Patricia Hachem; Jean-Marie Fourneau; Stéphane Sidobre; Mitchell Kronenberg; Masuru Taniguchi; Peter Van Endert; Michel Dy; Philip Askenase; Momtchilo Russo; B Boris Vargaftig; André Herbelin; Maria C Leite-de-Moraes
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

8.  Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.

Authors:  Shin-Ichiro Fujii; Kanako Shimizu; Caroline Smith; Laura Bonifaz; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

9.  Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.

Authors:  Tomohiro Yoshimoto; Booki Min; Takaaki Sugimoto; Nobuki Hayashi; Yuriko Ishikawa; Yuki Sasaki; Hitomi Hata; Kazuyoshi Takeda; Ko Okumura; Luc Van Kaer; William E Paul; Kenji Nakanishi
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

10.  CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  48 in total

1.  The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells.

Authors:  Sara Lind Enoksson; Emilie K Grasset; Thomas Hägglöf; Nina Mattsson; Ylva Kaiser; Susanne Gabrielsson; Tracy L McGaha; Annika Scheynius; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-01       Impact factor: 11.205

2.  Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.

Authors:  Sunil K Joshi; Gillian A Lang; T Scott Devera; Amy M Johnson; Susan Kovats; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-02-13       Impact factor: 4.962

3.  CD40L-null NKT cells provide B cell help for specific antibody responses.

Authors:  Hemangi B Shah; Sunil K Joshi; Mark L Lang
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

4.  Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.

Authors:  Li Bai; Shenglou Deng; Rachel Reboulet; Rebecca Mathew; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 5.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

6.  NK T cells provide lipid antigen-specific cognate help for B cells.

Authors:  Elizabeth A Leadbetter; Manfred Brigl; Petr Illarionov; Nadia Cohen; Megan C Luteran; Shiv Pillai; Gurdyal S Besra; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

Review 7.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

8.  Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.

Authors:  Gillian A Lang; Amy M Johnson; T Scott Devera; Sunil K Joshi; Mark L Lang
Journal:  Int Immunol       Date:  2011-03-12       Impact factor: 4.823

9.  Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.

Authors:  Pragya Rampuria; Gillian A Lang; T Scott Devera; Casey Gilmore; Jimmy D Ballard; Mark L Lang
Journal:  J Leukoc Biol       Date:  2016-08-26       Impact factor: 4.962

Review 10.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.